Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes

ConclusionsBoth clinical inertia and medication non-adherence remain significant barriers to optimal glycemic targets in type 2 diabetes. Moreover, part of clinical inertia may be a way through which clinicians face current uncertainty in medicine, including some dissonance among therapeutic guidelines. Scientific associations should find an agreement about how to measure and report clinical inertia in clinical practice and should exhort clinicians to consider reverse clinical inertia as a cause of persisting inappropriate therapy in vulnerable patients.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research